Centers for Disease Control and Prevention,National Center for HIV Viral Hepatitis STD and TB Prevention

This report presents statistics and trends for sexually transmitted diseases (STDs) in the United States through 2008. The information is based on (1) notifiable disease reporting from state and local STD programs; (2) projects that monitor STD prevalence in various settings, including the Regional Infertility Prevention Projects (IPP), the National Job Training Program, the Indian Health Service, the Men Who Have Sex with Men (MSM) Prevalence Monitoring Project, and the Gonococcal Isolate Surveillance Project (GISP); and (3) national surveys by federal and private organizations.

This report on the Gonococcal Isolate Surveillance Project (GISP), a national sentinel surveillance system that monitors trends in antimicrobial susceptibilities of strains of gonorrhea in the United States among selected sexually transmitted diseases clinics in about 25-30 sentinel sites. This report shows site-specific profiles of figures depicting the demographic and clinical data of the patients with gonorrhea enrolled in GISP and the antimicrobial susceptibility results of the gonorrhea isolates submitted.

This MMWR issue updates and combines earlier guidelines (published 2002 and 2004) for the prevention and treatment of opportunistic infections (OIs) in adults and adolescents infected with HIV. The guidelines were developed by a panel of specialists from the United States government and academic institutions and are intended for use by clinicians and other health care providers, HIV-infected patients, and policy makers in the United States. They address OIs that occur in the United States and five OIs that might be acquired during international travel.

This report provides information on the National Immunization Survey (NIS) which estimated vaccination coverage among children aged 19-35 months for 50 states and selected local areas. It describes the 2008 NIS coverage estimates for the 4:3:1:3:3:1 series and individual vaccines, 7-valent pneumococcal conjugate vaccine, =2 dose of Hepatitis A vaccine, and hepatitis B vaccine among children born during January 2005 - June 2007. Results demonstrate that the nation’s immunization program remained successful in maintaining high vaccination rates among young children.

This study discusses information on the 184 syringe exchange programs (SEPs) operating in 36 states, the District of Columbia, and Puerto Rico. Of these SEPs, 67% completed a mail/telephone survey conducted by North American Syringe Exchange Network (NASEN) and Beth Israel Medical Center, New York, which covered program operations for 2008. The report summarizes findings from the survey and compares them with results from a previous SEP survey for 1994-2007.

In this study, CDC reports on assessed hepatitis A vaccine coverage among children aged 12-23 months from 2006-2009, using data from eight Immunization Information System sentinel sites. Average hepatitis A vaccination coverage with =1 dose at the sites increased from 17 percent in 2006 to 47 percent in 2009. Average full vaccination coverage with =2 vaccine doses through age 23 months increased from one percent in 2006 to 15 percent in 2009. Vaccine coverage with =1 dose increased most during 2006 through the first quarter of 2007, then slowed.

This report describes CDC comparison of acute hepatitis C virus (HCV) surveillance data reported in 2008 from the National Notifiable Diseases Surveillance System (NNDS) and the Emerging Infections Program (EIP), which conducts enhanced surveillance for acute hepatitis C in selected states. Results show that 26 of 120 cases reported from EIP-funded sites were missing from NNDSS. Data on race and major HCV risk factors were missing from 22 percent and 60 percent of reports in NNDSS, compared with 8 percent and 25 percent of reports in EIP, respectively.

This Power Point presentation contains 181 slides that provide guidelines for the prevention and control of TB in correctional facilities, as recommended by CDC.

This serial updates the 2006 clinical guidelines for treating sexually transmitted diseases (STDs). These recommendations were developed by the Centers for Disease Control and Prevention (CDC) in consultation with professionals knowledgeable about the treatment of STDs.